Skip to content
Home/Companies/Biotech/STORM Therapeutics
ST

STORM Therapeutics

Biotech·UK·Active·10yr hold

STORM Therapeutics is a biotech company, headquartered in UK.

Entry
2016
Hold
10yr
Status
Active
Est. EV
–

Who owns STORM Therapeutics?

STORM Therapeutics is currently owned by Cambridge Innovation Capital through CIC Fund I (2013 vintage), since 2016.

Hand-verified · updated 2026-06-21

Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund I · 2013 · VC

Key facts

HQUK
SectorBiotech
StatusActive

More from CIC Fund I

Other portfolio companies in the same fund.

Seldon
Exited 2026
AI/MLUK· 2020
Gyroscope Therapeutics
Exited 2021
BiotechUK· 2019
to
PredictImmune
Exited 2024
HealthTechUK· 2019
Sense Biodetection
Active
MedTechUK· 2019
Audio Analytic
Exited 2022
AI/MLUK· 2017
to
Cytora
Exited 2025
InsurTechUK· 2017
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings